A Study of Polatuzumab Vedotin and Glofitamab in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma Within 12 Months After R-CHOP
Clinical trial NCT07702851 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07702851
- Sponsor
- Yonsei University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-01
- Primary completion
- 2030-08-31
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.